Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800559786> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2800559786 abstract "Keywords : Transforming growth factor beta inhibitor; treatment; keloid scar Objectives: The primary objective of this study was to evaluate the most appropriate transforming growth factor beta (TGF-β) inhibitor drug on keloid scars. Methods: Search strategy was done by using the PubMed, MEDLINE, and Wiley. The search terms were “keloids”, “treatment”, “transforming growth factor beta” and “scar”. Data was grouped and calculated proportionally, including 95% confidence interval by MEGASTAT. Results: The TGF-β inhibitor drugs were found to be effective in treating keloids. There was consistency in the same direction of the improvement in keloid appearance. Complications and recurrent rate of each drug were investigated. Major complications of bleomycin and fluorouracil were hyperpigmentation that occurred after using drugs, which gradually subside after discontinuation or applying of bleaching agent. Botulinum toxin had less complication, but its use was limited to some sites for keloid formation. Side effects of imiquimod were local skin reaction and lymphadenopathy. Mitomycin C had some reports of infected wound. Low recurrent rate was seen in bleomycin, botulinum toxin, imiquimod (only earlobes), and mitomycin C. Conclusion: TGF-β inhibitor drugs appeared to have less permanent side effects and lower recurrent rates in overall compared to the standard treatment; intralesional steroid. TGF-β inhibitor drugs were separated into the local infiltration group and the after surgery application group. For the local group, bleomycin and fluorouracil provided better results affecting keloids. Botulinum toxin injection was reported with a good result on keloids but its limitation on the injection site was still concerned. In the other group, mitomycin C was more effective than imiquimod. It could be applied on both earlobe and trunk with no systemic adverse effect. Therefore, TGF-β inhibitor drugs had proven to be a new effective option for keloids treatment." @default.
- W2800559786 created "2018-05-17" @default.
- W2800559786 creator A5029793514 @default.
- W2800559786 date "2016-06-02" @default.
- W2800559786 modified "2023-09-23" @default.
- W2800559786 title "A systematic review of transforming growth factor beta inhibitor treatments on keloid scars" @default.
- W2800559786 cites W1587376539 @default.
- W2800559786 cites W1977250838 @default.
- W2800559786 cites W1983076930 @default.
- W2800559786 cites W1995068456 @default.
- W2800559786 cites W2001203218 @default.
- W2800559786 cites W2005530413 @default.
- W2800559786 cites W2036421172 @default.
- W2800559786 cites W2036490556 @default.
- W2800559786 cites W2067788386 @default.
- W2800559786 cites W2078736392 @default.
- W2800559786 cites W2086006172 @default.
- W2800559786 cites W2087578245 @default.
- W2800559786 cites W2097403278 @default.
- W2800559786 cites W2115352529 @default.
- W2800559786 hasPublicationYear "2016" @default.
- W2800559786 type Work @default.
- W2800559786 sameAs 2800559786 @default.
- W2800559786 citedByCount "0" @default.
- W2800559786 crossrefType "journal-article" @default.
- W2800559786 hasAuthorship W2800559786A5029793514 @default.
- W2800559786 hasConcept C126322002 @default.
- W2800559786 hasConcept C141071460 @default.
- W2800559786 hasConcept C16005928 @default.
- W2800559786 hasConcept C2776232574 @default.
- W2800559786 hasConcept C2776694085 @default.
- W2800559786 hasConcept C2776728111 @default.
- W2800559786 hasConcept C2777478456 @default.
- W2800559786 hasConcept C2777538232 @default.
- W2800559786 hasConcept C2777642821 @default.
- W2800559786 hasConcept C2778715236 @default.
- W2800559786 hasConcept C2779112978 @default.
- W2800559786 hasConcept C2779338040 @default.
- W2800559786 hasConcept C71924100 @default.
- W2800559786 hasConceptScore W2800559786C126322002 @default.
- W2800559786 hasConceptScore W2800559786C141071460 @default.
- W2800559786 hasConceptScore W2800559786C16005928 @default.
- W2800559786 hasConceptScore W2800559786C2776232574 @default.
- W2800559786 hasConceptScore W2800559786C2776694085 @default.
- W2800559786 hasConceptScore W2800559786C2776728111 @default.
- W2800559786 hasConceptScore W2800559786C2777478456 @default.
- W2800559786 hasConceptScore W2800559786C2777538232 @default.
- W2800559786 hasConceptScore W2800559786C2777642821 @default.
- W2800559786 hasConceptScore W2800559786C2778715236 @default.
- W2800559786 hasConceptScore W2800559786C2779112978 @default.
- W2800559786 hasConceptScore W2800559786C2779338040 @default.
- W2800559786 hasConceptScore W2800559786C71924100 @default.
- W2800559786 hasLocation W28005597861 @default.
- W2800559786 hasOpenAccess W2800559786 @default.
- W2800559786 hasPrimaryLocation W28005597861 @default.
- W2800559786 hasRelatedWork W1954737706 @default.
- W2800559786 hasRelatedWork W2032655800 @default.
- W2800559786 hasRelatedWork W2069344652 @default.
- W2800559786 hasRelatedWork W2078736392 @default.
- W2800559786 hasRelatedWork W2095450626 @default.
- W2800559786 hasRelatedWork W2149196939 @default.
- W2800559786 hasRelatedWork W2293645536 @default.
- W2800559786 hasRelatedWork W2418868356 @default.
- W2800559786 hasRelatedWork W2509213993 @default.
- W2800559786 hasRelatedWork W2533835885 @default.
- W2800559786 hasRelatedWork W2580717095 @default.
- W2800559786 hasRelatedWork W2591571856 @default.
- W2800559786 hasRelatedWork W2610348286 @default.
- W2800559786 hasRelatedWork W2901855474 @default.
- W2800559786 hasRelatedWork W2912552414 @default.
- W2800559786 hasRelatedWork W2971208898 @default.
- W2800559786 hasRelatedWork W3020891677 @default.
- W2800559786 hasRelatedWork W3139514371 @default.
- W2800559786 hasRelatedWork W3177120355 @default.
- W2800559786 hasRelatedWork W3183682890 @default.
- W2800559786 hasVolume "40" @default.
- W2800559786 isParatext "false" @default.
- W2800559786 isRetracted "false" @default.
- W2800559786 magId "2800559786" @default.
- W2800559786 workType "article" @default.